Rat Junctional Adhesion Molecule B (His Tag) recombinant protein

Rat Junctional Adhesion Molecule B (His Tag) recombinant protein

• DataSheet
• Material Safety Data Sheets (MSDS)

Junctional adhesion molecule B (JAM-B), also known as Junctional adhesion molecule 2 (JAM2), Vascular endothelial junction-associated molecule (VE-JAM), and CD322, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily. It is prominently expressed on high endothelial venules. expression to be restricted to the high endothelial venule of tonsil and lymph nodes. The localization to the endothelium of arterioles in and around inflammatory and tumor foci. JAM-B can function as an adhesive ligand for the T cell line J45 and can interact with GM-CSF/IL-4-derived peripheral blood dendritic cells, circulating CD56(+) NK cells, circulating CD56(+)CD3(+) NK/T cells, and circulating CD56(+)CD3(+)CD8(+) cytolytic T cells. JAM-2 is expressed on high endothelial venules (HEVs) in human tonsil and on a subset of human leukocytes, suggesting that JAM-2 plays a central role in the regulation of transendothelial migration. It binds to very late activation antigen (VLA)-4, a leucocyte integrin that contributes to rolling and firm adhesion of lymphocytes to endothelial cells through binding to vascular cell adhesion molecule (VCAM)-1. JAM-B appears to contribute to leucocyte extravasation by facilitating not only transmigration but also rolling and adhesion. JAM-B acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.

Junctional adhesion molecule 2

2410030G21RIK; JAM2; PRO245; C21ORF43; JAM-B; UNQ219/PRO245; JAM-2; JCAM2; JAMB; CD322; JAM-IT/VE-JAM; 1110002N23RIK; 2410167M24RIK; VEJAM; RP23-253E17.2; AU016127; VE-JAM

Q3MHC0

Jam2

Human Cells

A DNA sequence encoding the rat JAM2 (Q3MHC0) (Met1-Asn236) was expressed, fused with a polyhistidine tag at the C-terminus.

Rat

The recombinant rat JAM2 comprises 219 amino acids and predicts a molecular mass of 24.7 kDa. The apparent molecular mass of the recombinant protein is approximately 43 kDa in SDS-PAGE under reducing conditions due to glycosylation.

> 90 % as determined by SDS-PAGE

Measured by its ability of the immobilized protein to support the adhesion of Jurkat human acute T cell leukemia cells.
When cells (8 x 104 cells/well) are added to ratJAM2-His coated plates (5 μg/mL, 100 μL/well), >30% will adhere after 60 minutes at 37℃.